Roumell Asset Management, LLC - ARIDIS PHARMACEUTICALS INC ownership

ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 22 filers reported holding ARIDIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Roumell Asset Management, LLC ownership history of ARIDIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$98,205
-30.0%
446,5880.0%0.19%
-39.3%
Q1 2023$140,273
-73.4%
446,5880.0%0.32%
-75.6%
Q4 2022$526,974
+27.0%
446,5880.0%1.30%
+45.3%
Q3 2022$415,000
-15.5%
446,5880.0%0.90%
-6.1%
Q2 2022$491,000
-37.5%
446,5880.0%0.96%
-24.7%
Q1 2022$786,000
-24.5%
446,5880.0%1.27%
-8.5%
Q4 2021$1,041,000
-18.6%
446,588
+28.5%
1.39%
-18.1%
Q3 2021$1,279,000
-36.7%
347,517
+27.3%
1.69%
-28.2%
Q2 2021$2,019,000
+54.0%
272,886
+22.8%
2.36%
+24.5%
Q1 2021$1,311,000222,2221.90%
Other shareholders
ARIDIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Wealth Architects, LLC 14,077$1,4370.00%
View complete list of ARIDIS PHARMACEUTICALS INC shareholders